I. Kulmagambetov

Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up

M. Stukova, Y. Burashev, K. Sultankulova, 2022, eClinicalMedicine.

Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan

M. Sergeeva, M. Stukova, K. Sultankulova, 2021, EClinicalMedicine.